Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
What are the available payment terms
Maintenance doses are typically given monthly, but some people may require injections every few months
danuglipron oral GLP-1 discontinued 2024 Key Peptide Products: Somavert (pegvisomant GH receptor antagonist), Genotropin (somatropin growth hormone peptide), BNT116/mRNA oncology vaccines, historical insulin franchise, Lupron (leuprolide US rights via Abbvie partnership) Therapeutic Segments: Oncology (Ibrance, Xtandi partnership, Padcev, Lorbrena)
1244-51 Hsieh, M.-J., et al., Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
US$ 20.32
US$ 23.99
US$ 21.32
